Skorupski, C., Mohammed, T., Chin-Yee, B., Gyawali, B., Lyman, G. H., Kuderer, N. M., & Hicks, L. K. (2022). Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021. In Blood (Vol. 140, pp. 5060–5061). American Society of Hematology. https://doi.org/10.1182/blood-2022-162981

Skorupski, Clarissa, Turab Mohammed, Benjamin Chin-Yee, Bishal Gyawali, Gary H. Lyman, Nicole M. Kuderer, and Lisa K. Hicks. “Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021.” In Blood, 140:5060–61. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-162981.

Skorupski C, Mohammed T, Chin-Yee B, Gyawali B, Lyman GH, Kuderer NM, et al. Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021. In: Blood. American Society of Hematology; 2022. p. 5060–1.

Skorupski, Clarissa, et al. “Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 5060–61. Crossref, doi:10.1182/blood-2022-162981.

Skorupski C, Mohammed T, Chin-Yee B, Gyawali B, Lyman GH, Kuderer NM, Hicks LK. Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021. Blood. American Society of Hematology; 2022. p. 5060–5061.